The Chicago Board Options Exchange (Cboe) has applied to list the staked Injective exchange-traded fund (ETF) shares proposed by Canary Capital, further expanding the wave of regulated crypto investment products in the United States.
Cboe's 19b-4 filing was submitted on Monday (July 28), following the investment firm Canary Capital's submission of an S-1 application for a staked Injective (INJ) token fund to the U.S. Securities and Exchange Commission (SEC), Cointelegraph reported.
The fund aims to accumulate staking rewards by providing validation services using "approved staking platforms."
If approved, this would be the third staked altcoin ETF following the approval of staked Solana (SOL) and staked Ethereum (ETH) ETFs on June 30.
The filing comes at a time when the regulatory environment under President Trump's administration is more favorable, supporting innovation in crypto investment tools.
The SEC has not yet formally acknowledged the ETF applications from Canary Capital and Cboe. Once acknowledged, the SEC will announce key deadlines for preliminary responses, typically within 30 to 45 days, possibly by early September.
However, the SEC's full review period could last up to 240 days, meaning the final decision on the staked INJ ETF may not be announced until March 2026.
In a key decision in May, the SEC ruled that staking does not violate securities laws. According to Alison Mangiero, head of staking policy at the Crypto Council for Innovation, this new guidance marks a "significant advancement" for the U.S. cryptocurrency industry.
She told Cointelegraph, "The SEC now recognizes our long-standing argument: staking is a core part of modern blockchain operations, not an investment contract," adding that this "clarity is crucial."
If approved, Canary Capital's ETF would provide traditional investors access to the governance token of the Injective protocol, enhancing the liquidity and visibility of the asset.
ETF inflows could help the utility token regain its historical high of $52 set on March 14, 2024. According to Cointelegraph data, the token is currently down over 71% from its previous peak, trading at $15.10.
For Bitcoin (BTC), ETF inflows accounted for about 75% of new investments in the world's first cryptocurrency, as its price surged above $50,000 after the first U.S. spot BTC ETF was approved in February 2024.
However, the market's reaction to the Ethereum spot ETF has been relatively muted.
TradingView data shows that Ethereum's price dropped over 38% within two weeks of the U.S. trading launch of the spot ETF in 2024, falling from $3,441 on July 23 to a local low of $2,116 on August 5, before starting to recover.
Farside Investors data indicates that Grayscale's Ethereum ETF (ETHE) has seen significant selling pressure, with net outflows exceeding $4.3 billion, making it the only losing Ethereum ETF issuer.
Related: Nasdaq-listed Mill City Ventures invests $441 million into Sui treasury
Original article: “Cboe files application to list staked Injective ETF launched by Canary Capital”
免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。
